Enter inventor name

Stephen Gregory DiMagno

USPTO Granted Patents = 25 (Patent Applications = 11)

Average Co-Inventor Count = 1.5

ph-index = 8

Forward Citations = 375(Granted Patents)

Location History:

Philadelphia, PA (US) (1994 - 1999)
Lincoln, NE (US) (1997 - 2016)
Chicago, IL (US) (2018 - 2024)

Company Filing History:

13 out of 924

University of Nebraska

patents

10 out of 2,597

University of Pennsylvania

University of California

where one patent can have more than one assignee

Years Active: 1994-2024

Loading Chart...

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11939617 - Functionally modified polypeptides and radiobiosynthesis (2024-03-26),

2. 11666654 - Drug delivery system for treating disease (2023-06-06),

3. 11214820 - Functionally modified polypeptides and radiobiosynthesis (2022-01-04),

4. 10112893 - Guanidinium compounds (2018-10-30),

5. 10053423 - Radioiodinated compounds (2018-08-21),

6. 9302990 - Fluorination of aromatic ring systems (2016-04-05),

7. 9278959 - Processes and reagents for making diaryliodonium salts (2016-03-08),

8. 8546578 - Iodonium Cyclophanes for SECURE arene functionalization (2013-10-01),

9. 8377704 - Detection and quantification of anions (2013-02-19),

10. 7744851 - [object Object] (2010-06-29),

11. 7592486 - Anhydrous fluoride salts and reagents and methods for their production (2009-09-22),

12. 7429596 - 1H-pyrrolo [2,3-D] pyrimidine derivatives and methods of use thereof (2008-09-30),

13. 6392032 - Heavily fluorinated sugar analogs (2002-05-21),

14. 6124452 - Octafluoro-meso-tetraarylporphyrins and methods for making these (2000-09-26),

15. 6100392 - Electron-deficient porphyrins and processes and intermediates for (2000-08-08),

Title: Innovations by Stephen Gregory DiMagno: A Leader in Modified Polypeptides and Drug Delivery Systems

Introduction

Stephen Gregory DiMagno is a prominent inventor based in Lincoln, NE, who has made significant contributions to the field of biomedical engineering and therapeutic development. With a remarkable portfolio of 25 patents, DiMagno has demonstrated his dedication to advancing medical science through innovative solutions.

Latest Patents

Among his notable recent patents, DiMagno has developed a method for creating functionally modified polypeptides. This invention focuses on utilizing non-natural amino acids (nnAAs) within genetic machinery to produce modified polypeptides, which are particularly effective in therapeutic scenarios. Notably, the modified polypeptides are designed to bind to serum albumin, enhancing their utility in drug delivery.

Another significant invention encompasses a drug delivery system utilizing HPMA-CBz copolymers. This system provides methods for treating various diseases by administering these copolymers to affected subjects, showcasing DiMagno's commitment to addressing complex health challenges.

Career Highlights

DiMagno's career has been marked by his association with esteemed institutions, including the University of Pennsylvania and Nutech Ventures. These experiences have not only contributed to his personal growth as an inventor but have also played a crucial role in the development and advancement of his groundbreaking patents.

Collaborations

Throughout his innovative journey, DiMagno has collaborated with talented individuals, including Michael J Therien and Haoran Sun. These partnerships have enriched his work and contributed to the successful realization of several of his inventive projects.

Conclusion

Stephen Gregory DiMagno continues to be a pivotal figure in the field of biotechnology, with his patents paving the way for future treatments and therapies. His focus on innovative drug delivery systems and modified polypeptides reflects a significant step forward in enhancing therapeutic efficacy and patient care.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com